Characteristics of 241 invasive and non-invasive Haemophilus influenzae isolated from patients under 14 years old, Hebei Province, China
- PMID: 41013420
- PMCID: PMC12465515
- DOI: 10.1186/s12879-025-11396-2
Characteristics of 241 invasive and non-invasive Haemophilus influenzae isolated from patients under 14 years old, Hebei Province, China
Abstract
Background: The introduction of the Haemophilus influenzae type b (Hib) vaccine has led to significant variations in the epidemiological patterns of H.influenzae globally, with regional differences. However, large sample pathogenetic studies and comparative analyses of H.influenzae in China remain limited, especially in Hebei Province. This study aimed to characterize the patterns in serotypes and the antimicrobial resistance of invasive and non-invasive H.influenzae in children under 14 years of age in Hebei Province.
Methods: An observational study was conducted from January 2019 to December 2021 at Hebei Children's Hospital. H.influenzae was identified using classical biochemical methods, MALDI-TOF MS and hpd gene-based qPCR. Slide agglutination serotyping and molecular capsular typing determined the capsular types. Antimicrobial resistance was tested with the broth dilution method and Kirby-Bauer disk diffusion method, and β-lactamase production was detected using nitrocefin disks.
Results: Among 241 H.influenzae isolates, 13 were invasive and 228 were non-invasive. The proportion of invasive isolates differed significantly across age groups (P = 0.005), i.e., 14.55% among patients < 1 year of age, 0.00% among 1-2 years of age, 4.26% among 3-5 years of age, and 2.33% in the 6-13 age groups. Three capsular types were detected: Hib (10/241), Hie (2/241), and Hif (7/241), with 222 isolates identified as NTHi. Hib accounted for 61.54% of the invasive isolate. Antimicrobial susceptibility tests also showed that invasive isolates exhibited higher nonsensitivity to cefuroxime, ceftriaxone, cefepime, imipenem, meropenem, and clarithromycin compared to non-invasive isolates (P < 0.05). The percentage of BLNAI and BLNAR was also higher for invasive isolates than in non-invasive ones (46.15% vs. 20.61%, P = 0.042).
Conclusions: Although NTHi is becoming the predominant pathogen of H.influenzae infection in children under 14 years, Hib remains the leading cause of invasive infection in Hebei Province. The high prevalence of β-lactamase-producing and BLNAR isolates underscores a growing challenge in antimicrobial resistance, particularly among invasive isolates.
Keywords: Haemophilus influenzae; Antimicrobial resistance; Invasive; Non-invasive; Serotype; β-lactamase.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki, and it was approved by the Ethics Committee of Hebei Children's Hospital (Approval No. 2019023). Written informed consent was obtained from the participants or their guardians. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures


References
-
- Centre for Disease Prevention and Control. Haemophilus influenzae. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-8-haemophilus.... Accessed 13 Aug 2024.
-
- Subspeciality Group of Infectious Diseases, the Society of Pediatrics, Chinese Medical Association; Group of Infectious Disease Surveillance of Pediatrics; Editorial Board, Chinese Journal of Pediatrics. Expert consensus on diagnosis and treatment of Haemophilusinfluenzae infection in children. Zhonghua Er Ke Za Zhi. 2019;57(9):663–8. 10.3760/cma.j.issn.0578-1310.2019.09.004. - PubMed
-
- Li JP, Hua CZ, Sun LY, et al. Epidemiological features and antibiotic resistance patterns of Haemophilus influenzae originating from respiratory tract and vaginal specimens in pediatric patients. J Pediatr Adolesc Gynecol. 2017;30(6):626–31. 10.1016/j.jpag.2017.06.002. - PubMed
-
- Wahl B, O’Brien KL, Greenbaum A, et al. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Health. 2018;6(7):e744–57. 10.1016/S2214-109X(18)30247-X. - PMC - PubMed
-
- World Health Organization. H.influenzae type b (Hib) vaccination position paper. 2013. https://www.who.int/publications/i/item/who-wer8839-413-426. Accessed 13 Aug 2024.
Publication types
MeSH terms
Substances
Grants and funding
- 2022YFC2704904/National Key Research and Development Program of China
- 19277769D/Hebei Provincial Department of Science and Technology, People's Republic of China
- 102393220020020000029/National Institute for Communicable Disease Prevention and Control, Chinese Center for Disease Control and Prevention
LinkOut - more resources
Full Text Sources
Medical